scientific controls and cancer controls

Placebo controls: scientific and ethical issues.

What controls PTEN and what it controls (in prostate cancer).

T he standard of care for metastatic prostate cancer (PCa) is androgen deprivation therapy since almost all PCa growth is initially reliant on the androgen receptor (AR). However, almost all patients develop resistance to this therapy within 18–24 months, and current treatment for castration-resistant prostate cancer (CRPC) is extremely limited, despite the advent of new drugs that target the A...

Comparison of Plasma Taurine Levels between Patients with Esophageal Cancer and Healthy Controls

ABSTRACT           Background and Objectives: The incidence rate of esophageal cancer (EC) is high in north and northeast of Iran. Taurine is a sulfur-containing amino acid with a wide range of vital biological functions. The aim of this study was to compare plasma levels of taurine between patients with EC and healthy controls.    &...

Comparison of periodontal parameters among cardiovascular patients and healthy controls

Background: This study was performed to evaluate periodontal status in patients with cardiovascular disease (CVD) and assessment of periodontal diseases prevalence in these patients. Materials and Methods: In this cross-sectional study, data on 100 patients were collected with mean age of 51 ± 11 years. The case group included of 50 patients with confirmed CVD who referred to Ali-ibn ...

Fundamental concepts of radiopharmaceuticals quality controls

Quality control (QC) procedures should always be performed following radiopharmaceutical preparation and prior to patient administration. The main aim of QC is to ensure optimal radiopharmaceutical product properties except for some short half-life tracers such as some positron emission tomography (PET) imaging probs. by dispensing a radiopharmaceutical of the highest quality the risk of having...